Market Place
Sourcing Support
Neuronetics Reports Q4 and Full Year 2024 Financial Results
27 Mar 2025 //
GLOBENEWSWIRE
Neuronetics to Report Q4 2024 Financial and Operating Results
21 Feb 2025 //
GLOBENEWSWIRE
Neuronetics Launches Underwritten Public Offering of Stock
06 Feb 2025 //
GLOBENEWSWIRE
NeuroStar Unveils 2 Significant Publications on TMS Therapy
29 Jan 2025 //
GLOBENEWSWIRE
NeuroStar Presents at AACAP 2024 on TMS and Depression
14 Oct 2024 //
GLOBENEWSWIRE
NeuroStar® Releases Software Upgrades to Elevate Patient Care
16 Sep 2024 //
GLOBENEWSWIRE
NeuroStar Honors Suicide Prevention Month with Milestone Achievement
03 Sep 2024 //
GLOBENEWSWIRE
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
20 Aug 2024 //
GLOBENEWSWIRE
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month
01 Aug 2024 //
GLOBENEWSWIRE
NeuroStar® Launches Better Me Provider Program Nationwide
01 Jul 2024 //
GLOBENEWSWIRE
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
13 Jun 2024 //
GLOBENEWSWIRE
NeuroStar TMS Advances Adolescent Mental Health Treatment
01 May 2024 //
GLOBENEWSWIRE
NeuroStar Advanced Therapy Enhanced With Wi-Fi Capabilities
06 Apr 2023 //
GLOBENEWSWIRE
NeuroStar Advanced Therapy Receives Patient Impact Award from Life Sciences PA
16 Mar 2023 //
GLOBENEWSWIRE
FDA Clears NeuroStar Advanced Therapy for Mental Health in Anxious Depression
19 Jul 2022 //
GLOBENEWSWIRE
NeuroStar Advanced Therapy for Mental Health Receives FDA Clearance for OCD
10 May 2022 //
GLOBENEWSWIRE
NeuroStar Advanced Therapy Partners with Mental Health Advocate
03 May 2022 //
GLOBENEWSWIRE
NeuroStar Adv. Therapy Launches New Tap Into Campaign for Depression Awareness
03 Mar 2022 //
GLOBENEWSWIRE
Neuronetics Launches Enhanced Digital Resource Center for NeuroStar Providers
14 Jul 2021 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.